15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 11 firms covering Crocs Inc, 5 rate it Buy or better, 5 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $81.00 to $160.00, a moderate spread. The average target of $124.40 sits 9% below the current $135.99. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $3.54 next quarter toward $14.54 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 ratings
Moderate Buy
Strong Buy00%
Buy545%
Hold545%
Sell19%
Strong Sell00%
Based on 11 analysts giving stock ratings to Crocs Inc.
As of Jul, 5 of 11 firms rate CROX a Buy (5 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
CROX EPS & revenue forecast
EPS · NEXT QUARTER
$3.54
Range $3.41 – $3.84 · 13 analysts · +21% YoY
Next period, 13 analysts expect Crocs Inc to earn $3.54 a share (range $3.41 – $3.84), versus $2.92 a year earlier. Full-year consensus is $13.68, growing to $14.54 the year after.
REVENUE · NEXT QUARTER
$1.0B
Range $1.0B – $1.1B · 13 analysts · +2% YoY
Revenue is expected to reach $1.0B (range $1.0B – $1.1B), +2.5% year-over-year. Full-year consensus is $4.1B, rising to $4.2B next year.
Top analysts covering Crocs Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CROX.
#1
Tom Nikic
Needham
Buy
$132.00-2.9% to target
Coverage
—
+ Follow
#2
Adrienne Yih
Barclays
Hold
$110.00-19.1% to target
Coverage
—
+ Follow
#3
CN
Christopher Nardone
B of A Securities
Buy
$160.00+17.7% to target
Coverage
—
+ Follow
#4
Anna Andreeva
Piper Sandler
Buy
$150.00+10.3% to target
Coverage
—
+ Follow
#5
PM
Peter McGoldrick
Stifel Nicolaus
Hold
$125.00-8.1% to target
Coverage
—
+ Follow
CROX stock forecast FAQ
What is CROX's average 12-month price target?+
The 9 analysts with a live target average $124.40 for Crocs Inc over the next 12 months, ranging from a $160.00 high to a $81.00 low.
Is CROX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 11 analyst ratings, 5 are Buy or Strong Buy, 5 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for CROX?+
The Street-high target is $160.00 (B of A Securities), and the Street-low is $81.00 (Goldman Sachs). The average of all 9 active targets is $124.40.
How many Wall Street analysts cover CROX?+
11 analysts have an active rating on Crocs Inc, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering CROX?+
Among analysts who currently cover CROX, Tom Nikic of Needham has the strongest overall Quantellect track record. Their current call is Buy with a $132.00 target.
What is Crocs Inc's projected EPS for next quarter?+
The consensus estimate is $3.54 per share (range $3.41 – $3.84) across 13 analysts. Full-year EPS is projected at $13.68, rising to $14.54 the following year.
How much revenue is Crocs Inc expected to report next quarter?+
Consensus revenue is $1.0B (range $1.0B – $1.1B). Full-year revenue is projected at $4.1B, growing to $4.2B next year.
Have analysts been upgrading or downgrading CROX lately?+
As of Jul, 5 of 11 firms rate CROX a Buy (5 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CROX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
